Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Carreno

Showing results (131-140 of 135) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 135 results.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Therapeutic scheduling of WEE1 inhibition preserves T cell function and promotes immune control of HPV⁺ tumorsYing Liu, Zhiheng Zhang, Yanshan Tao, et al.
Cancer Cell|January 1, 2026
Antigen-specific profiling identifies T-bet<sup>+</sup> melanoma-specific CD8<sup>+</sup> T cells associated with response to neoadjuvant PD-1 blockadeGuanning Wang, Daniel Yoon, Ajeya Nandi, et al.
JCI Insight|October 11, 2022
Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicitiesTimothy S Olson, Benjamin F Frost, Jamie L Duke, et al.
Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Pageof 14

Showing results (131-140 of 135) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 135 results.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Therapeutic scheduling of WEE1 inhibition preserves T cell function and promotes immune control of HPV⁺ tumorsYing Liu, Zhiheng Zhang, Yanshan Tao, et al.
Cancer Cell|January 1, 2026
Antigen-specific profiling identifies T-bet<sup>+</sup> melanoma-specific CD8<sup>+</sup> T cells associated with response to neoadjuvant PD-1 blockadeGuanning Wang, Daniel Yoon, Ajeya Nandi, et al.
JCI Insight|October 11, 2022
Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicitiesTimothy S Olson, Benjamin F Frost, Jamie L Duke, et al.
Blood Cancer Discovery|November 22, 2022
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line TherapyAlfred L Garfall, Adam D Cohen, Sandra P Susanibar-Adaniya, et al.
Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.
Pageof 14